In this process, NG2 acts as an important player in reactivating RTK signaling, as supported by our data showing that NG2 knockout relieves the feedback activation of RTKs and improves the response of BRAF-mutant thyroid cancer cells to BRAF inhibitor. The gene discussed is CSPG4; the disease is thyroid gland carcinoma.